✦ LIBER ✦

Clinical Efficacy and Management of Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Lymphoma

✍ Scribed by Coiffier, Bertrand

Book ID: 121416569
Publisher: Elsevier
Year: 2013
Tongue: English
Weight: 402 KB
Volume: 13
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2013.04.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Temsirolimus and rituximab in patients w

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study

✍ Stephen M Ansell; Hui Tang; Paul J Kurtin; Patricia A Koenig; David J Inwards; K 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 162 KB

Phase III Study to Evaluate Temsirolimus

Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

✍ Hess, G.; Herbrecht, R.; Romaguera, J.; Verhoef, G.; Crump, M.; Gisselbrecht, C. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 155 KB

Lenalidomide in combination with rituxim

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial

✍ Michael Wang; Luis Fayad; Nicolaus Wagner-Bartak; Liang Zhang; Fredrick Hagemeis 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 141 KB

Phase 2 trial of rituximab and bortezomi

Phase 2 trial of rituximab and bortezomib in patients with relapsed or refractory mantle cell and follicular lymphoma

✍ Robert A. Baiocchi; Lapo Alinari; Mark E. Lustberg; Thomas S. Lin; Pierluigi Por 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

Lenalidomide oral monotherapy produces a

Lenalidomide oral monotherapy produces a high response rate in patients with relapsed or refractory mantle cell lymphoma

✍ Thomas M. Habermann; Izidore S. Lossos; Glen Justice; Julie M. Vose; Peter H. Wi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Pentostatin demonstrates clinical activi

Pentostatin demonstrates clinical activity in patients with relapsed or refractory non-Hodgkin's lymphoma

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB